Table 3. Clinical Variables.
| Variable | Levene's homogenity test | ANOVA | Post-hoc comparisons | Tukey–Kramar HSD | Games–Howell |
|---|---|---|---|---|---|
| CAPS | F(2,86)=36.067, p<0.001 | NA | PTSD−DS and PTSD+DS | NA | t(3, 22)=2.473, NS |
| BDI | F(2, 81)=17.439, p<0.001 | NA | PTSD−DS and PTSD+DS | NA | t(3, 15)=2.530, NS |
| CTQ | F(2, 86)=19.499, p<0.001 | NA | PTSD−DS and PTSD+DS | NA | t(3, 27)=1.475, NS |
| PTSD−DS and Control | NA | t(3, 41)=6.93, p<0.001 | |||
| PTSD+DS and Control | NA | t(3, 13)=6.880, p<0.001 | |||
| MDI Total | F(2, 85)=18.724, p<0.001 | NA | PTSD−DS and PTSD+DS | NA | t(3, 17)=4.700, p=0.001 |
| PTSD−DS and Control | NA | t(3, 38)=7.250, p<0.001 | |||
| PTSD+DS and Control | NA | t(3, 34)=9.238, p<0.001 |
Abbreviations: BLA, basolateral amygdala baseline activity; BDI, Becks Depression Inventory; CAPS, Clinician Administered PTSD Scale; CMA, Centromedial amygdala baseline activity; Control, age-matched control group; CTQ, Childhood Trauma Questionnaire; MDI, Multiscale Dissociation Inventory; NA, not applicable; PTSD+DS, dissociative subtype PTSD group; PTSD−DS, non-dissociative PTSD group.